Metatarsophalangeal (MTP) joint arthropathy, commonly known as big toe arthritis, can cause significant pain and limit your daily activities. Traditional treatments like rest, injections, and even joint fusion (arthrodesis) have drawbacks. Enter Cartiva, a synthetic cartilage implant promising to restore joint function without sacrificing movement.
Get A 100% Free CASE Evaluation
The Cartiva SCI, a molded cylinder made of PVA hydrogel, has faced mounting concerns over premature failure rates. Patients who received the big toe implant are alleging widespread complications, including severe pain, loosening, fractures, and other issues and say these failures caused them to have additional surgery for big toe fusion.
A recent study published in Cureus delved into the short-term outcomes of Cartiva surgery for MTP arthropathy. While the findings offer hope, the results are concerning.
Researchers found that though some patients saw improved function and returned to their usual activities within two years:
Cartiva offers a potential alternative for MTP arthropathy, but it’s not a magic bullet. While it can improve function and reduce pain for some, persistent pain, complications, and the possibility of further surgery are realities to consider.
If you have suffered from complications after receiving a Cartiva Toe Implant, contact us now. We are fighting to protect the rights of patients allegedly injured by Cartiva toe implants and hold the device makers fully accountable for putting profits above the health and well-being of patients.
Patients who received a Cartiva toe implant and suffered complications including being forced to have revision surgery to remove or replace the device, may be entitled to significant financial compensation. Contact us now to learn more about your rights and whether you are entitled to compensation.
Sources
Cureus | Surgical Outcomes of Synthetic Cartilage Implant Hemiarthroplasty for Metatarsophalangeal Arthropathy | Article
The Cartiva SCI, a molded cylinder made of PVA hydrogel, has faced mounting concerns over premature failure rates. Patients who received the big toe implant are alleging widespread complications, including severe pain, loosening, fractures, and other issues and say these failures caused them to have additional surgery for big toe fusion.
A recent study published in Cureus delved into the short-term outcomes of Cartiva surgery for MTP arthropathy. While the findings offer hope, the results are concerning.
Researchers found that though some patients saw improved function and returned to their usual activities within two years:
Cartiva offers a potential alternative for MTP arthropathy, but it’s not a magic bullet. While it can improve function and reduce pain for some, persistent pain, complications, and the possibility of further surgery are realities to consider.
If you have suffered from complications after receiving a Cartiva Toe Implant, contact us now. We are fighting to protect the rights of patients allegedly injured by Cartiva toe implants and hold the device makers fully accountable for putting profits above the health and well-being of patients.
Patients who received a Cartiva toe implant and suffered complications including being forced to have revision surgery to remove or replace the device, may be entitled to significant financial compensation. Contact us now to learn more about your rights and whether you are entitled to compensation.
Sources
Cureus | Surgical Outcomes of Synthetic Cartilage Implant Hemiarthroplasty for Metatarsophalangeal Arthropathy | Article
